Literature DB >> 9352253

Muramic acid in human peripheral blood leucocytes in different age groups.

L Lehtonen1, E Eerola, P Toivanen.   

Abstract

Presence of muramic acid (as a marker for bacterial cell wall peptidoglycan) was analysed by gas chromatography and mass spectrometry in the peripheral blood leucocytes of subjects from a range of ages (9-80 years) and groups (healthy individuals, patients with rheumatoid arthritis, osteoarthrosis, essential hypertension or multiple sclerosis). Sixty per cent of the sample from the youngest subjects contained detectable muramic acid. The percentage of people with circulating leucocytes containing muramic acid decreased gradually with age, being less than 5% in all groups over 40 years. No clear correlation between the presence of muramic acid and the disease was observed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352253     DOI: 10.1046/j.1365-2362.1997.1950732.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments.

Authors:  G J Merkel; B A Scofield
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 2.  Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.

Authors:  P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

3.  Influence of major histocompatibility complex on bacterial composition of fecal flora.

Authors:  P Toivanen; J Vaahtovuo; E Eerola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls.

Authors:  X Zhang; M Rimpiläinen; E Simelyte; P Toivanen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.